Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05592548 · ClinicalTrials.gov registry record · NA
Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device
A NA study, sponsored by The Skin Center Dermatology Group.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05592548 is a NA study that has completed, run by The Skin Center Dermatology Group. The registered enrollment target is 5 participants.
The verdict
NCT05592548, a NA study, has completed, sponsored by The Skin Center Dermatology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device
Interventions
- DEVICE cold atmospheric plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05592548
The ClinicalTrials.gov registry entry for NCT05592548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Skin Center Dermatology Group, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cold atmospheric plasma is the first listed.
NCT05592548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05592548 about?
NCT05592548 is a clinical study titled "Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device". 10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device
What is the current status of trial NCT05592548?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2024-01-02. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05592548?
The interventions under investigation include: cold atmospheric plasma (DEVICE).
Who is sponsoring clinical trial NCT05592548?
This trial is sponsored by The Skin Center Dermatology Group, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.